FDA Clearance Tracker · P160032-S014
Lifeline/ReviveR DDU-100, Lifeline/ReviveR AUTO DDU-120, Lifeline/ReviveR VIEW DDU-2300, Lifeline/ReviveR VIEW AUTO DDU-
Last checked: Nov 20, 2026Latest source record: Jul 24, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Jul 24, 2026
Approved
Time to decision
380 days
Received Jul 9, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P160032-S014
- Device name
- Lifeline/ReviveR DDU-100, Lifeline/ReviveR AUTO DDU-120, Lifeline/ReviveR VIEW DDU-2300, Lifeline/ReviveR VIEW AUTO DDU-
- Applicant
- Defibtech, LLC
- Applicant location
- Guilford, CT
- Received
- Jul 9, 2025
- Decided
- Jul 24, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P160032
Device type
- Device class
- Class III
- Regulation
- 21 CFR 870.5310
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
extending the Defibtech DDU-2000 series AED to the new VIEW 2 series which include models: Lifeline VIEW 2 model DDU-2950, Lifeline VIEW 2 AUTO DDU-2955, Lifeline ECG 2 DDU-2960, and the Universal Pads accessory model DDP-2004.
Source documents
Other decisions for Defibtech, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K211289 · Decided Nov 9, 2021 · 195 days after receipt
Device type: Compressor, Cardiac, External (DRM) · Cardiology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.